Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Clinical trial NCT07606352 · RECRUITING
Trial details
- NCT number
- NCT07606352
- Sponsor
- Sitala Bio LTD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2027-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.